Corrigendum to "Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancer" [J. Control. Release 239 (2016) 39-48]
1 Institut für Molekulare Immunologie und Experimentelle Onkologie, Klinikum rechts der Isar, Technische Universität München, Ismaninger Straße 22, 81675 München, Germany.
2 Rega Institute for Medical Research, Department Microbiology and Immunology, KU Leuven, Belgium.
3 Department of Industrial Chemistry "Toso Montanari", University of Bologna, Viale Risorgimento 4, 40136 Bologna, Italy.
4 Nanomaterials Research Center, Institute of Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 5290002, Israel.
5 Department of Medicine, Tel Aviv University, Tel Aviv, Israel.
6 Department of Industrial Chemistry "Toso Montanari", University of Bologna, Viale Risorgimento 4, 40136 Bologna, Italy. Electronic address: mauro.comesfranchini@unibo.it.